NCT02756832 An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2 Status COMPLETED Phase N/A
NCT02756819 International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan Status COMPLETED Phase N/A
NCT02748694 Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study Status COMPLETED Phase PHASE1
NCT02747927 Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Status COMPLETED Phase PHASE3
NCT02743949 Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) Status COMPLETED Phase PHASE2
NCT02743806 Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease Status TERMINATED Phase PHASE4
NCT02728895 Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT Status COMPLETED Phase PHASE1
NCT02723201 TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants Status COMPLETED Phase PHASE1
NCT02716987 Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration Status COMPLETED Phase PHASE1
NCT02716116 A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02713061 A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants Status WITHDRAWN Phase PHASE2
NCT02709746 Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT02709655 Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT02706834 Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02706626 Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors Status TERMINATED Phase PHASE2
NCT02695719 Lubiprostone for Treatment of Chronic Idiopathic Constipation Status COMPLETED Phase PHASE3
NCT02685007 RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study Status COMPLETED Phase N/A